Participant guide
How studies are reviewed and monitored
A generalized anxiety disorder study cannot enroll you, or anyone else, until an independent committee has reviewed it. That review does not end on day one. It keeps going for as long as the study runs.
Updated
Independent review
The committee is called an Institutional Review Board, or IRB, and it is independent of the researchers. Before a generalized anxiety disorder study starts, the IRB reviews the study plan and the consent document you would be given. The review carries on while the study is under way. The IRB's job is to protect the rights and welfare of the people taking part, and that includes you if you join.
Who runs generalized anxiety disorder studies
As of November 16, 2026, 42 generalized anxiety disorder studies are recruiting participants in the United States, according to ClinicalTrials.gov. By sponsor: university, hospital or other (29), industry (13). The sponsor is the organization responsible for a study.
See which generalized anxiety disorder studies are recruiting near you.
Federal rules
Federal regulations govern research in the United States. They set out how you must be informed and protected as a participant. If the generalized anxiety disorder study you are considering involves a medication or a device, the U.S. Food and Drug Administration oversees it as well.
Monitoring during the study
You will have scheduled visits where the study team follows your health. They record any problems you report. A study can be changed, paused, or stopped if a serious concern appears.
Risk goes down with oversight. It never goes to zero. Every study carries risks, a generalized anxiety disorder study included, and the known ones are described in the consent document.
Talk with a study coordinator
A coordinator can explain which generalized anxiety disorder studies may fit you and what the next step looks like. Call (888) 927-7410 or send a short form. You commit to nothing by asking questions.
Sources and further reading
- Institutional Review Boards (IRBs) and Protection of Human Subjects in Clinical Trials — U.S. Food and Drug Administration
- Regulations to Protect Research Participants — HHS Office for Human Research Protections
- 45 CFR 46 — Protection of Human Subjects — U.S. Department of Health and Human Services